» Articles » PMID: 21445240

Molecular Determinants of S100B Oligomer Formation

Overview
Journal PLoS One
Date 2011 Mar 30
PMID 21445240
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: S100B is a dimeric protein that can form tetramers, hexamers and higher order oligomers. These forms have been suggested to play a role in RAGE activation.

Methodology/principal Findings: Oligomerization was found to require a low molecular weight trigger/cofactor and could not be detected for highly pure dimer, irrespective of handling. Imidazol was identified as a substance that can serve this role. Oligomerization is dependent on both the imidazol concentration and pH, with optima around 90 mM imidazol and pH 7, respectively. No oligomerization was observed above pH 8, thus the protonated form of imidazol is the active species in promoting assembly of dimers to higher species. However, disulfide bonds are not involved and the process is independent of redox potential. The process was also found to be independent of whether Ca(2+) is bound to the protein or not. Tetramers that are purified from dimers and imidazol by gel filtration are kinetically stable, but dissociate into dimers upon heating. Dimers do not revert to tetramer and higher oligomer unless imidazol is again added. Both tetramers and hexamers bind the target peptide from p53 with retained stoichiometry of one peptide per S100B monomer, and with high affinity (lgK = 7.3±0.2 and 7.2±0.2, respectively in 10 mM BisTris, 5 mM CaCl(2), pH 7.0), which is less than one order of magnitude reduced compared to dimer under the same buffer conditions.

Conclusion/significance: S100B oligomerization requires protonated imidazol as a trigger/cofactor. Oligomers are kinetically stable after imidazol is removed but revert back to dimer if heated. The results underscore the importance of kinetic versus thermodynamic control of S100B protein aggregation.

Citing Articles

ROS anchor PAMPs-mediated extracellular HMGB1 self-association and its dimerization enhances pro-inflammatory signaling.

Kwak M, Han M, Lee Y, Choi S, Kim J, Park I Redox Biol. 2025; 80:103521.

PMID: 39908862 PMC: 11847140. DOI: 10.1016/j.redox.2025.103521.


Time-Dependent Changes in the Biofluid Levels of Neural Injury Markers in Severe Traumatic Brain Injury Patients-Cerebrospinal Fluid and Cerebral Microdialysates: A Longitudinal Prospective Pilot Study.

Lin I, Kamnaksh A, Aniceto R, McCullough J, Bekdash R, Eklund M Neurotrauma Rep. 2023; 4(1):107-117.

PMID: 36895820 PMC: 9989523. DOI: 10.1089/neur.2022.0076.


Computational Design of Macrocyclic Binders of S100B(ββ): Novel Peptide Theranostics.

Kannan S, Aronica P, Nguyen T, Li J, Verma C Molecules. 2021; 26(3).

PMID: 33573254 PMC: 7866529. DOI: 10.3390/molecules26030721.


Targeting S100B with Peptides Encoding Intrinsic Aggregation-Prone Sequence Segments.

Cristovao J, Romao M, Gallardo R, Schymkowitz J, Rousseau F, Gomes C Molecules. 2021; 26(2).

PMID: 33467751 PMC: 7830867. DOI: 10.3390/molecules26020440.


Allosteric modulation of protein oligomerization: an emerging approach to drug design.

Gabizon R, Friedler A Front Chem. 2014; 2:9.

PMID: 24790978 PMC: 3982530. DOI: 10.3389/fchem.2014.00009.


References
1.
Harpio R, Einarsson R . S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma. Clin Biochem. 2004; 37(7):512-8. DOI: 10.1016/j.clinbiochem.2004.05.012. View

2.
Smith S, Shaw G . A novel calcium-sensitive switch revealed by the structure of human S100B in the calcium-bound form. Structure. 1998; 6(2):211-22. DOI: 10.1016/s0969-2126(98)00022-7. View

3.
McClintock K, Shaw G . A novel S100 target conformation is revealed by the solution structure of the Ca2+-S100B-TRTK-12 complex. J Biol Chem. 2002; 278(8):6251-7. DOI: 10.1074/jbc.M210622200. View

4.
Schafer B, Heizmann C . The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem Sci. 1996; 21(4):134-40. DOI: 10.1016/s0968-0004(96)80167-8. View

5.
Drohat A, Baldisseri D, Rustandi R, Weber D . Solution structure of calcium-bound rat S100B(betabeta) as determined by nuclear magnetic resonance spectroscopy,. Biochemistry. 1998; 37(9):2729-40. DOI: 10.1021/bi972635p. View